{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:18:51Z","timestamp":1767413931810,"version":"3.48.0"},"reference-count":29,"publisher":"Japanese Association for Laboratory Animal Science","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1538\/expanim.25-0065","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T22:07:58Z","timestamp":1756764478000},"page":"73-80","source":"Crossref","is-referenced-by-count":0,"title":["Early-stage therapeutic efficacy of TNAP inhibition using a novel milder murine model of CKD-MBD"],"prefix":"10.1538","volume":"75","author":[{"given":"Kaori","family":"Soma","sequence":"first","affiliation":[{"name":"Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Mill\u00e1n","sequence":"additional","affiliation":[{"name":"Sanford Burnham Prebys, 10901 North Torrey Pines Road, La Jolla, CA 92037,              USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Pinkerton","sequence":"additional","affiliation":[{"name":"Boundless Bio, 10955 Alexandria Way, Suite 100, San Diego, CA 92121,              USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Izumi","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Levey              AS, Atkins              R, Coresh              J, Cohen              EP, Collins              AJ, Eckardt              KU, et            al. Chronic kidney disease as a global public health            problem: approaches and initiatives - a position statement from Kidney Disease Improving            Global Outcomes. Kidney Int. 2007;            72: 247\u2013259.","DOI":"10.1038\/sj.ki.5002343"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moe              S, Dr\u00fceke              T, Cunningham              J, Goodman              W, Martin              K, Olgaard              K, et            al. Kidney Disease: Improving Global Outcomes            (KDIGO). Definition, evaluation, and classification of            renal osteodystrophy: a position statement from Kidney Disease: Improving Global            Outcomes (KDIGO). Kidney Int. 2006;            69: 1945\u20131953.","DOI":"10.1038\/sj.ki.5000414"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamada              S, Nakano              T. Role of            chronic kidney disease (CKD) \u2212 Mineral and Bone Disorder (MBD) in the pathogenesis of            cardiovascular disease in CKD. J Atheroscler Thromb.            2023; 30: 835\u2013850.","DOI":"10.5551\/jat.RV22006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Waziri              B, Duarte              R, Naicker              S. Chronic            kidney disease \u2212 mineral and bone disorder (CKD-MBD): current            perspectives. Int J Nephrol Renovasc Dis.            2019; 12: 263\u2013276.","DOI":"10.2147\/IJNRD.S191156"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lundquist              AL, Nigwekar              SU. Optimal            management of bone mineral disorders in chronic kidney disease and end stage renal            disease. Curr Opin Nephrol Hypertens.          2016; 25: 120\u2013126.","DOI":"10.1097\/MNH.0000000000000203"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yang              HC, Zuo              Y, Fogo              AB. Models of            chronic kidney disease. Drug Discov Today Dis Models.            2010; 7: 13\u201319.","DOI":"10.1016\/j.ddmod.2010.08.002"},{"key":"7","unstructured":"7. Han              Y, Lu              JS, Xu              Y, Zhang              L, Hong              BF. Rutin            ameliorates renal fibrosis and proteinuria in 5\/6-nephrectomized rats by anti-oxidation            and inhibiting activation of TGF\u03b21-smad signaling. Int J Clin            Exp Pathol. 2015; 8:            4725\u20134734."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Askari              H, Seifi              B, Kadkhodaee              M. Evaluation            of renal-hepatic functional indices and blood pressure based on the progress of time in            a rat model of chronic kidney disease. Nephrourol Mon.            2016; 8: e37840.","DOI":"10.5812\/numonthly.37840"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ghosh              SS, Massey              HD, Krieg              R, Fazelbhoy              ZA, Ghosh              S, Sica              DA, et            al. Curcumin ameliorates renal failure in 5\/6            nephrectomized rats: role of inflammation. Am J Physiol Renal            Physiol. 2009; 296:            F1146\u2013F1157.","DOI":"10.1152\/ajprenal.90732.2008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dedinszki              D, Szeri              F, Koz\u00e1k              E, Pomozi              V, T\u0151k\u00e9si              N, Mezei              TR, et            al. Oral administration of pyrophosphate inhibits            connective tissue calcification. EMBO Mol Med.            2017; 9: 1463\u20131470.","DOI":"10.15252\/emmm.201707532"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. O\u2019Neill              WC,                Lomashvili              KA, Malluche              HH, Faugere              MC, Riser              BL. Treatment            with pyrophosphate inhibits uremic vascular calcification.            Kidney Int. 2011; 79:            512\u2013517.","DOI":"10.1038\/ki.2010.461"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pinkerton              AB, Sergienko              E, Bravo              Y, Dahl              R, Ma              CT, Sun              Q, et            al. Discovery of 5-((5-chloro-2-methoxyphenyl)            sulfonamido) nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific            alkaline phosphatase (TNAP) inhibitor. Bioorg Med Chem            Lett. 2018; 28:            31\u201334.","DOI":"10.1016\/j.bmcl.2017.11.024"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mill\u00e1n              JL. The role of            phosphatases in the initiation of skeletal mineralization.            Calcif Tissue Int. 2013; 93:            299\u2013306.","DOI":"10.1007\/s00223-012-9672-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Buchet              R, Mill\u00e1n              JL, Magne              D.            Multisystemic functions of alkaline phosphatases.            Methods Mol Biol. 2013; 1053:            27\u201351.","DOI":"10.1007\/978-1-62703-562-0_3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Savinov              AY, Salehi              M, Yadav              MC, Radichev              I, Mill\u00e1n              JL, Savinova              OV. Transgenic            overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium            results in generalized arterial calcification. J Am Heart            Assoc. 2015; 4: e002499.","DOI":"10.1161\/JAHA.115.002499"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Goettsch              C,                Strzelecka-Kiliszek              A, Bessueille              L, Quillard              T, Mechtouff              L, Pikula              S, et            al. TNAP as a therapeutic target for cardiovascular            calcification: a discussion of its pleiotropic functions in the body.            Cardiovasc Res. 2022; 118:            84\u201396.","DOI":"10.1093\/cvr\/cvaa299"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Romanelli              F, Corbo              A, Salehi              M, Yadav              MC, Salman              S, Petrosian              D, et            al. Overexpression of tissue-nonspecific alkaline            phosphatase (TNAP) in endothelial cells accelerates coronary artery disease in a mouse            model of familial hypercholesterolemia. PLoS One.            2017; 12: e0186426.","DOI":"10.1371\/journal.pone.0186426"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sheen              CR, Kuss              P, Narisawa              S, Yadav              MC, Nigro              J, Wang              W, et            al. Pathophysiological role of vascular smooth            muscle alkaline phosphatase in medial artery calcification. J            Bone Miner Res. 2015; 30:            824\u2013836.","DOI":"10.1002\/jbmr.2420"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Narisawa              S, Harmey              D, Yadav              MC, O\u2019Neill              WC, Hoylaerts              MF, Mill\u00e1n              JL. Novel            inhibitors of alkaline phosphatase suppress vascular smooth muscle cell            calcification. J Bone Miner Res. 2007;            22: 1700\u20131710.","DOI":"10.1359\/jbmr.070714"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ziegler              SG, Ferreira              CR,                MacFarlane              EG, Riddle              RC, Tomlinson              RE, Chew              EY, et            al. Ectopic calcification in pseudoxanthoma            elasticum responds to inhibition of tissue-nonspecific alkaline            phosphatase. Sci Transl Med. 2017;            9: eaal1669.","DOI":"10.1126\/scitranslmed.aal1669"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Li              Q, Huang              J, Pinkerton              AB, Mill\u00e1n              JL, van Zelst              BD, Levine              MA, et            al. Inhibition of tissue-nonspecific alkaline            phosphatase attenuates ectopic mineralization in the Abcc6(\u2212\/\u2212) mouse model of PXE but            not in the Enpp1 mutant mouse models of GACI. J Invest            Dermatol. 2019; 139:            360\u2013368.","DOI":"10.1016\/j.jid.2018.07.030"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bessueille              L, Kawtharany              L, Quillard              T, Goettsch              C, Briolay              A, Taraconat              N, et            al. Inhibition of alkaline phosphatase impairs            dyslipidemia and protects mice from atherosclerosis. Transl            Res. 2023; 251:            2\u201313.","DOI":"10.1016\/j.trsl.2022.06.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tani              T, Fujiwara              M, Orimo              H, Shimizu              A, Narisawa              S, Pinkerton              AB, et            al. Inhibition of tissue-nonspecific alkaline            phosphatase protects against medial arterial calcification and improves survival            probability in the CKD-MBD mouse model. J Pathol.            2020; 250: 30\u201341.","DOI":"10.1002\/path.5346"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gorgels              TG, Hu              X, Scheffer              GL, van der                Wal              AC, Toonstra              J, de Jong              PT, et            al. Disruption of Abcc6 in the mouse: novel insight            in the pathogenesis of pseudoxanthoma elasticum. Hum Mol            Genet. 2005; 14:            1763\u20131773.","DOI":"10.1093\/hmg\/ddi183"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Soma              K, Izumi              M, Yamamoto              Y, Miyazaki              S, Watanabe              K. In vitro and            in vivo pharmacological profiles of DS-1211, a novel potent, selective, and orally            bioavailable tissue-nonspecific alkaline phosphatase inhibitor.            J Bone Miner Res. 2022; 37:            2033\u20132043.","DOI":"10.1002\/jbmr.4680"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Soma              K, Watanabe              K, Izumi              M.            Anticalcification effects of DS-1211 in pseudoxanthoma elasticum mouse            models and the role of tissue-nonspecific alkaline phosphatase in ABCC6-deficient            ectopic calcification. Sci Rep. 2022;            12: 19852.","DOI":"10.1038\/s41598-022-23892-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mornet              E.            Hypophosphatasia. Orphanet J Rare Dis.            2007; 2: 40.","DOI":"10.1186\/1750-1172-2-40"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Whyte              MP.            Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and            treatment. Nat Rev Endocrinol. 2016;            12: 233\u2013246.","DOI":"10.1038\/nrendo.2016.14"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mill\u00e1n              JL, Whyte              MP. Alkaline            phosphatase and hypophosphatasia. Calcif Tissue Int.            2016; 98: 398\u2013416.","DOI":"10.1007\/s00223-015-0079-1"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/75\/1\/75_25-0065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:14:18Z","timestamp":1767413658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/75\/1\/75_25-0065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.25-0065","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"type":"print","value":"1341-1357"},{"type":"electronic","value":"1881-7122"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0065"}}